The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score: A Nationwide Cohort Study

Gregory Y. H Lip; Peter Br?nnum Nielsen; Flemming Skj?th; Deirdre A Lane; Lars Hvilsted Rasmussen; Torben Bjerregaard Larsen

首页> 外文期刊>Chest >The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score: A Nationwide Cohort Study

【24h】

The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score: A Nationwide Cohort Study

机译：欧洲心血管病学会根据房颤卒中评分中的抗凝和危险因素，将心房纤颤患者的卒中风险分层细化为低风险的价值：一项全国性队列研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Chest》 |2014年第5期|共10页
作者
Gregory Y. H Lip; Peter Br?nnum Nielsen; Flemming Skj?th; Deirdre A Lane; Lars Hvilsted Rasmussen; Torben Bjerregaard Larsen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. The value of the European Society of Cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorized as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: A Nationwide Cohort Study [J] . LipG.Y.H., NielsenP.B., Skj?thF., Chest: The Journal of Circulation, Respiration and Related Systems . 2014,第5期

机译：欧洲心脏病学会指南对心房纤颤卒中评分中的抗凝和危险因素进行分类，将房颤患者中风风险分层细化为低风险的价值：一项全国性队列研究
2. Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA(2)DS(2)-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum" [J] . Asinger Richard W., Shroff Gautam R., Herzog Charles A. Circulation: An Official Journal of the American Heart Association . 2016,第18期

机译：Asinger等人关于文章的信，“房颤和1个中风危险因素（CHA（2）DS（2）-VASc男性得分1，女性2分）的患者应抗凝吗？是：甚至有1个中风危险因子发生中风的真正风险”和“应将具有房颤和1个中风危险因素（CHA（2）DS（2）-VASc男性为1，女性为2）的患者抗凝治疗吗？：CHA（2）DS（2 ）-VASc 1难题：风险范围较低端的决策”
3. Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA(2)DS(2)-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA(2)DS(2)-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum" [J] . Asinger Richard W., Shroff Gautam R., Herzog Charles A. Circulation: An Official Journal of the American Heart Association . 2016,第18期

机译：Asinger等人关于文章的信，“房颤和1个中风危险因素（CHA（2）DS（2）-VASc男性得分1，女性2分）的患者应抗凝吗？是：甚至有1个中风危险因子发生中风的真正风险”和“应将具有房颤和1个中风危险因素（CHA（2）DS（2）-VASc男性为1，女性为2）的患者抗凝治疗吗？：CHA（2）DS（2 ）-VASc 1难题：风险范围较低端的决策”
4. Ambient Air Pollution and the Risk of Stroke and Atrial Fibrillation: A Population-Based Cohort Study [C] . Saeha Shin, Rick Burnett, Jeffrey C. Kwong, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：周围空气污染与中风和心房颤动的风险：一项基于人群的队列研究
5. High sensitivity C-reactive protein and risk of stroke in atrial fibrillation: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study [D] . Dawood, Farah Z. 2015

机译：高敏C反应蛋白和房颤的卒中风险：卒中地理和种族差异的原因（REGARDS）研究
6. Atrial fibrillation anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology [O] . Katarzyna Mizia‐Stec, Alida L.P. Caforio, Philippe Charron, 2020

机译：心房颤动抗凝管理和中风的风险心肌病欧洲心脏病学会欧洲生态学研究计划的心肌病
7. Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts” [O] . Jonathan P. Piccini, Susanna R. Stevens, YuChiao Chang, 2013

机译：回应关于物品的信，“肾功能障碍是非衰弱性心房颤动患者中风和全身栓塞的预测因子：验证R 2 Chads 2指数在火箭AF中（rivaroxaban曾经每日，口服，直接因子XA抑制相比维生素K对患者预防心房颤动的卒中和栓塞试验的拮抗剂）和Atria（心房颤动的抗凝和危险因素）研究队列“

The Value of the European Society of Cardiology Guidelines for Refining Stroke Risk Stratification in Patients With Atrial Fibrillation Categorized as Low Risk Using the Anticoagulation and Risk Factors in Atrial Fibrillation Stroke Score: A Nationwide Cohort Study

著录项

相似文献

相关主题

期刊订阅